RECTAL SQUAMOUS CELL CARCINOMA
Clinical trials for RECTAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new RECTAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for RECTAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy trial aims to boost survival in rare rectal cancer
Disease control Recruiting nowThis study is testing whether adding a PD-1 immunotherapy drug to standard chemotherapy and radiation improves outcomes for people with a rare type of rectal cancer. It will enroll about 20 adults with newly diagnosed, non-metastatic rectal squamous cell carcinoma. The main goal …
Matched conditions: RECTAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University • Aim: Disease control
Last updated Apr 01, 2026 18:26 UTC
-
Tailored attack on HIV-Linked anal cancer tests gentler vs. stronger approach
Disease control Recruiting nowThis study is testing two personalized treatment plans for anal cancer in people living with HIV. For patients with low-risk cancer, researchers are testing a reduced dose of chemotherapy and radiation to see if it's effective with fewer side effects. For patients with high-risk …
Matched conditions: RECTAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC